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Background
Several human monoclonal antibodies (hmAbs) includ-
ing Fab X5, b12, 2G12 and 2F5 exhibit relatively potent
and broad HIV-1 neutralizing activity. These antibodies
are highly divergent from the closest corresponding germ-
line antibodies. We have hypothesized that the high
degree of specific somatic hypermutations may preclude
binding of the HIV-1 envelope glycoprotein (Env) to their
corresponding germline antibodies, and that identifying
antibodies that are intermediates in the pathways to mat-
uration could help design novel vaccine immunogens.
Such immunogens may not be based on the Env but help
guide the immune system through the long complex path-
ways to maturation.
Methods
We have designed germline-like antibodies where several
different CDR3s of the heavy chain were used including
one which is identical to that of the mature antibody.
Results
The germline-like X5 bound with high affinity to all tested
Envs and neutralized a panel of HIV-1 isolates from differ-
ent clades. In contrast, none of the other germline-like
antibodies (b12, 2G12 and 2F5) including antibodies in
multivalent formats bound to any of the Envs and did not
neutralize any of the HIV-1 isolate tested although the cor-
responding mature antibodies did with high level of activ-
ity. Because b12 is best characterized in terms of structure/
function relationships we selected it for characterization
of possible maturation pathways. We identified a panel of
possible b12 intermediate antibodies and several antigens
not related to the Env that bind to some of these antibod-
ies.
Conclusion
These antigens together with Envs could be used as a con-
ceptually novel type of candidate vaccines based on two or
more immunogens that help guiding the immune system
through the complex maturation pathways for elicitation
of antibodies that are similar or identical to antibodies
with known properties.
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